Live Science on MSN2h
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowA nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance last spring.
A bipartisan group of legislators have introduced a bill at the roundhouse that would allow New Mexicans to take psychedelic ...
A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The ...
Legislation to create a program for the medicinal use of psilocybin was introduced today in the New Mexico Senate. Senate Bill 219, the Medical Psilocybin Act, would allow those in New Mexico to ...
A group of lawmakers introduced a proposal Thursday to establish a program for medicinal use of psilocybin mushrooms.
The Cambridge, Mass., biotechnology company on Thursday said it received a notice of allowance from the U.S. Patent and Trademark Office regarding the drug candidate, ED-003, which is intended to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback